Circulating biomarkers are associated with disease severity of chronic hand eczema and atopic dermatitis
British Journal of Dermatology · 2023
DOI: 10.1093/bjd/ljad110 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, 2023. Verfasst von Anna S Quaade und 7 weiteren Autor:innen. Beteiligte Einrichtung: The National Allergy Research Centre, Department of Dermatology and Allergy, Copenhagen University Hospital Herlev-Gentofte, Hellerup, Denmark. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Eczema. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LEO Foundation.
Abstract (Originalsprache)
Background
Although chronic hand eczema (CHE) is a highly prevalent and disabling skin disease, it is currently unknown if CHE is associated with systemic inflammation.
Objectives
To characterize the plasma inflammatory signature of CHE.
Methods
Using Proximity Extension Assay technology, we assessed 266 inflammatory and cardiovascular disease risk proteins in the plasma of 40 healthy controls, 57 patients with atopic dermatitis (AD) with active lesions, 11 with CHE and a history of AD (CHEPREVIOUS_AD), and 40 with CHE and no history of AD (CHENO_AD). Filaggrin gene mutation status was also assessed. Protein expression was compared between groups and according to disease severity. Correlation analyses for biomarkers, and clinical- and self-reported variables, were performed.
Results
Very severe CHENO_AD was associated with systemic inflammation when compared with controls. Levels of T helper (Th)2- and Th1-, general inflammation and eosinophil activation markers increased with severity of CHENO_AD, primarily being significantly increased in very severe disease. Significant, positive correlations were found between markers from these pathways and severity of CHENO_AD. Moderate-to-severe but not mild AD displayed systemic inflammation. The Th2 markers C-C motif chemokine (CCL)17 and CCL13 (also known as monocyte chemotactic protein 4) were the top differentially expressed proteins in both very severe CHENO_AD and moderate-to-severe AD, showing a higher fold change and significance in AD. CCL17 and CCL13 levels further correlated positively with disease severity in both CHENO_AD and AD.
Conclusions
Systemic Th2-driven inflammation is shared between very severe CHE with no history of AD, and moderate-to-severe AD, suggesting that Th2 cell targeting could be effective in several CHE subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The National Allergy Research Centre, Department of Dermatology and Allergy, Copenhagen University Hospital Herlev-Gentofte, Hellerup, Denmark.
- Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- The National Allergy Research Centre, Copenhagen University Hospital Herlev-Gentofte, Hellerup, Denmark.
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
ORCID-Profile: Anna S Quaade, Xing Wang, Julie B K Sølberg, Nina H Ulrich, Benjamin D McCauley, Jacob P Thyssen, Christine Becker, Jeanne D Johansen
Förderung
- LEO Foundation
Zitieren
APA
Quaade, A. S., Wang, X., Sølberg, J. B. K., Ulrich, N. H., McCauley, B. D., Thyssen, J. P., Becker, C., & Johansen, J. D. (2023). Circulating biomarkers are associated with disease severity of chronic hand eczema and atopic dermatitis. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad110
Vancouver
Quaade AS, Wang X, Sølberg JBK, Ulrich NH, McCauley BD, Thyssen JP, et al. Circulating biomarkers are associated with disease severity of chronic hand eczema and atopic dermatitis. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad110
BibTeX
@article{Quaade2023,
author = {Quaade, Anna S and Wang, Xing and Sølberg, Julie B K and Ulrich, Nina H and McCauley, Benjamin D and Thyssen, Jacob P and Becker, Christine and Johansen, Jeanne D},
title = {Circulating biomarkers are associated with disease severity of chronic hand eczema and atopic dermatitis},
journal = {British Journal of Dermatology},
year = {2023},
doi = {10.1093/bjd/ljad110}
}
EUVIMED